Your browser doesn't support javascript.
loading
Results of a randomized phase III/IV trial comparing intermittent bolus versus continuous infusion of antihaemophilic factor (recombinant) in adults with severe or moderately severe haemophilia A undergoing major orthopaedic surgery.
Pabinger, Ingrid; Mamonov, Vasily; Windyga, Jerzy; Engl, Werner; Doralt, Jennifer; Tangada, Srilatha; Spotts, Gerald; Ewenstein, Bruce.
Affiliation
  • Pabinger I; Medical University of Vienna, Vienna, Austria.
  • Mamonov V; National Research Center for Hematology, Moscow, Russia.
  • Windyga J; Department of Disorders of Hemostasis and Internal Medicine, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Engl W; Baxalta Innovations GmbH, a Takeda company, Vienna, Austria.
  • Doralt J; Baxalta Innovations GmbH, a Takeda company, Vienna, Austria.
  • Tangada S; Baxalta US Inc., a Takeda company, Cambridge, Massachusetts, USA.
  • Spotts G; Baxalta US Inc., a Takeda company, Cambridge, Massachusetts, USA.
  • Ewenstein B; Baxalta US Inc., a Takeda company, Cambridge, Massachusetts, USA.
Haemophilia ; 27(3): e331-e339, 2021 May.
Article in En | MEDLINE | ID: mdl-33772963
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Orthopedic Procedures / Hemophilia A Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2021 Document type: Article Affiliation country: Austria Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Orthopedic Procedures / Hemophilia A Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2021 Document type: Article Affiliation country: Austria Country of publication: Reino Unido